Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors.
作者信息
Strumberg D, Voliotis D, Moeller J G, Hilger R A, Richly H, Kredtke S, Beling C, Scheulen M E, Seeber S
机构信息
University of Essen, West German Cancer Center, Essen, Germany.
出版信息
Int J Clin Pharmacol Ther. 2002 Dec;40(12):580-1. doi: 10.5414/cpp40580.
DOI:10.5414/cpp40580
PMID:12503822
Abstract
摘要
Zotero 插件